FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955474401> ?p ?o ?g. }

• W2955474401 endingPage "e467" @default.
• W2955474401 startingPage "e467" @default.
• W2955474401 abstract "Rituximab is used widely for desensitization in ABO-incompatible and donor-specific antibody-positive kidney transplantation. However, data about the effects of individual differences in rituximab-induced B-cell suppression on antibody-mediated rejection (AMR) remain unknown. We aimed to assess the association between CD19-positive rate and AMR following rituximab administration after kidney transplantation.Overall, 42 patients who underwent rituximab therapy for pretransplant desensitization in ABO-incompatible (n = 33) and donor-specific antibody-positive (n = 15) kidney transplantation were observed retrospectively. To predict AMR incidence, the peripheral blood CD19-positive rate was determined and classified into short- and long-acting groups. AMR incidence, allograft function, complications, and rituximab dose were compared.Eight patients (19%) had AMR within 39.2 months after transplantation. The CD19-positive rate cutoff value to predict AMR incidence was 4.4%, 6.4%, and 7.7% at 6, 12, and 18 months after transplantation, respectively. When comparing the short- and long-acting groups stratified according to the CD19-positive rate cutoff value, AMR incidence was significantly higher in the short-acting group than in the long-acting group at 6 (71.4% vs 8.6%), 12 (70.0% vs 3.1%), and 18 (58.3% vs 3.3%) months after transplantation. The CD19-positive rate for all patients with AMR exceeded the cutoff value 6, 12, or 18 months. Conversely, serum creatinine level, tacrolimus trough-level, cytomegalovirus antigenemia-positive rate, neutropenia incidence rate, and total dose of rituximab before transplantation showed no significant differences between the 2 groups.The risk of AMR was higher in patients with short-term B-cell suppression following rituximab administration. Additional rituximab administration after transplantation may prevent AMR in patients with a CD19-positive rate higher than the cutoff value." @default.
• W2955474401 created "2019-07-12" @default.
• W2955474401 creator A5001329634 @default.
• W2955474401 creator A5007919399 @default.
• W2955474401 creator A5017779882 @default.
• W2955474401 creator A5025911766 @default.
• W2955474401 creator A5038934036 @default.
• W2955474401 date "2019-06-27" @default.
• W2955474401 modified "2023-10-18" @default.
• W2955474401 title "Association Between Peripheral Blood CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients" @default.
• W2955474401 cites W1566672148 @default.
• W2955474401 cites W1973346712 @default.
• W2955474401 cites W1979794631 @default.
• W2955474401 cites W1981367546 @default.
• W2955474401 cites W1983005038 @default.
• W2955474401 cites W1986037486 @default.
• W2955474401 cites W2006326109 @default.
• W2955474401 cites W2070487938 @default.
• W2955474401 cites W2082556444 @default.
• W2955474401 cites W2092382141 @default.
• W2955474401 cites W2121183119 @default.
• W2955474401 cites W2121960517 @default.
• W2955474401 cites W2127001878 @default.
• W2955474401 cites W2139856839 @default.
• W2955474401 cites W2148022022 @default.
• W2955474401 cites W2170256066 @default.
• W2955474401 cites W2324499989 @default.
• W2955474401 cites W2493124393 @default.
• W2955474401 cites W2518564757 @default.
• W2955474401 cites W2591717879 @default.
• W2955474401 cites W2619495634 @default.
• W2955474401 cites W2683912726 @default.
• W2955474401 cites W2757341623 @default.
• W2955474401 cites W2774126255 @default.
• W2955474401 doi "https://doi.org/10.1097/txd.0000000000000907" @default.
• W2955474401 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6616141" @default.
• W2955474401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31334341" @default.
• W2955474401 hasPublicationYear "2019" @default.
• W2955474401 type Work @default.
• W2955474401 sameAs 2955474401 @default.
• W2955474401 citedByCount "1" @default.
• W2955474401 countsByYear W29554744012023 @default.
• W2955474401 crossrefType "journal-article" @default.
• W2955474401 hasAuthorship W2955474401A5001329634 @default.
• W2955474401 hasAuthorship W2955474401A5007919399 @default.
• W2955474401 hasAuthorship W2955474401A5017779882 @default.
• W2955474401 hasAuthorship W2955474401A5025911766 @default.
• W2955474401 hasAuthorship W2955474401A5038934036 @default.
• W2955474401 hasBestOaLocation W29554744011 @default.
• W2955474401 hasConcept C120665830 @default.
• W2955474401 hasConcept C121332964 @default.
• W2955474401 hasConcept C126322002 @default.
• W2955474401 hasConcept C126894567 @default.
• W2955474401 hasConcept C159641895 @default.
• W2955474401 hasConcept C159654299 @default.
• W2955474401 hasConcept C170493617 @default.
• W2955474401 hasConcept C176080213 @default.
• W2955474401 hasConcept C203014093 @default.
• W2955474401 hasConcept C2779779143 @default.
• W2955474401 hasConcept C2780303639 @default.
• W2955474401 hasConcept C2780306776 @default.
• W2955474401 hasConcept C2780653079 @default.
• W2955474401 hasConcept C2909675724 @default.
• W2955474401 hasConcept C2911091166 @default.
• W2955474401 hasConcept C61511704 @default.
• W2955474401 hasConcept C64518967 @default.
• W2955474401 hasConcept C71924100 @default.
• W2955474401 hasConcept C90924648 @default.
• W2955474401 hasConceptScore W2955474401C120665830 @default.
• W2955474401 hasConceptScore W2955474401C121332964 @default.
• W2955474401 hasConceptScore W2955474401C126322002 @default.
• W2955474401 hasConceptScore W2955474401C126894567 @default.
• W2955474401 hasConceptScore W2955474401C159641895 @default.
• W2955474401 hasConceptScore W2955474401C159654299 @default.
• W2955474401 hasConceptScore W2955474401C170493617 @default.
• W2955474401 hasConceptScore W2955474401C176080213 @default.
• W2955474401 hasConceptScore W2955474401C203014093 @default.
• W2955474401 hasConceptScore W2955474401C2779779143 @default.
• W2955474401 hasConceptScore W2955474401C2780303639 @default.
• W2955474401 hasConceptScore W2955474401C2780306776 @default.
• W2955474401 hasConceptScore W2955474401C2780653079 @default.
• W2955474401 hasConceptScore W2955474401C2909675724 @default.
• W2955474401 hasConceptScore W2955474401C2911091166 @default.
• W2955474401 hasConceptScore W2955474401C61511704 @default.
• W2955474401 hasConceptScore W2955474401C64518967 @default.
• W2955474401 hasConceptScore W2955474401C71924100 @default.
• W2955474401 hasConceptScore W2955474401C90924648 @default.
• W2955474401 hasIssue "7" @default.
• W2955474401 hasLocation W29554744011 @default.
• W2955474401 hasLocation W29554744012 @default.
• W2955474401 hasLocation W29554744013 @default.
• W2955474401 hasLocation W29554744014 @default.
• W2955474401 hasLocation W29554744015 @default.
• W2955474401 hasOpenAccess W2955474401 @default.
• W2955474401 hasPrimaryLocation W29554744011 @default.
• W2955474401 hasRelatedWork W1509822413 @default.
• W2955474401 hasRelatedWork W1977185862 @default.
• W2955474401 hasRelatedWork W1986059809 @default.

• next